← All organizations
Highest phase reached
Phase 4
First clinical trial
Jan 1, 2013Last known activity
Jun 30, 2025
Timeline
2010s
- Jan 1, 2013
Spanish Clinical Research Network— Founded
Drugs by trial phase (27 distinct, 19 trials)
Phase 4 (8 own, 0 via acquisition)
Phase 3 (14 own, 0 via acquisition)
Phase 2 (4 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Recent trials (21)
- NCT06905834CollaboratorPhase 2Jun 30, 2025
- NCT06423898CollaboratorPhase 4Oct 9, 2024
- NCT06513533CollaboratorPhase 2/Phase 3Apr 23, 2024
- NCT05780073CollaboratorPhase 2Oct 16, 2023
- NCT05774236CollaboratorPhase 3Mar 27, 2023
- NCT05086939CollaboratorPhase 3May 26, 2021
- NCT04860739Lead sponsorPhase 2Apr 24, 2021
- NCT04860739Overall official - principal investigatorPhase 2Apr 24, 2021
- NCT05378191CollaboratorPhase 2Apr 22, 2021
- NCT05378191Overall official - principal investigatorPhase 2Apr 22, 2021
- NCT04197089CollaboratorPhase 4Dec 31, 2019
- NCT03738917CollaboratorPhase 4Feb 1, 2019
- NCT03718273CollaboratorPhase 3Oct 19, 2018
- NCT03373318CollaboratorPhase 4Jan 10, 2018
- NCT03236090CollaboratorN/AJul 15, 2017
Details
- Founded
- Madrid, ES Jan 1, 2013
- Last known activity
- Jun 30, 2025